Breast Cancer: Risk Assessment and Prevention

被引:8
作者
Hooks, Mary A. [1 ]
机构
[1] E Tennessee State Univ, Dept Surg, Johnson City, TN 37614 USA
关键词
breast cancer epidemiology; breast cancer prevention; breast cancer risk assessment; breast cancer risk calculation; breast cancer risk factors; REDUCING SALPINGO-OOPHORECTOMY; SURGICAL ADJUVANT BREAST; POSTMENOPAUSAL WOMEN; YOUNG-WOMEN; TAMOXIFEN; RALOXIFENE; THERAPY; PATIENT; DISEASE; BRCA1;
D O I
10.1097/SMJ.0b013e3181d39038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Breast cancer is the most common cancer and the second most common cause of cancer death in women. In 2008 there were 182,460 women diagnosed with breast cancer, and 40,480 women died of this disease.(1) Breast cancer can be prevented by medical (tamoxifen or raloxifene) or surgical approaches (bilateral mastectomy or oophorectomy). Prevention is only recommended for women at high risk for developing breast cancer; therefore, proper risk calculation is essential in identifying women that may benefit from prevention measures. There is an easy-to-use and easily accessible risk calculation tool for determining a woman's risk of developing breast cancer and need for referral for counseling, gene testing, and possibly preventive therapy. This article reviews the components of risk assessment, the most frequently used risk calculation tool, and approaches to breast cancer risk reduction including medical and surgical therapies. The use of these therapies results in a risk reduction of 50-90%.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 29 条
[1]  
[Anonymous], NCCN PRACT GUID ONC
[2]   Assessing the risk of breast cancer. [J].
Armstrong, K ;
Eisen, A ;
Weber, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) :564-571
[3]   Effect of screening and adjuvant therapy on mortality from breast cancer [J].
Berry, DA ;
Cronin, KA ;
Plevritis, SK ;
Fryback, DG ;
Clarke, L ;
Zelen, M ;
Mandelblatt, JS ;
Yakovlev, AY ;
Habbema, JDF ;
Feuer, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792
[4]   Surgical prevention of cancer [J].
Bertagnolli, MM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (02) :324-332
[5]   Reported drop in mammography - Is this cause for concern? [J].
Breen, Nancy ;
Cronin, Kathleen A. ;
Meissner, Helen I. ;
Taplin, Stephen H. ;
Tangka, Florence K. ;
Tiro, Jasmin A. ;
McNeel, Timothy S. .
CANCER, 2007, 109 (12) :2405-2409
[6]  
Clarke M, 1998, LANCET, V351, P1451
[7]   Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].
Ettinger, B ;
Black, DM ;
Mitlak, BH ;
Knickerbocker, RK ;
Nickelsen, T ;
Genant, HK ;
Christiansen, C ;
Delmas, PD ;
Zanchetta, JR ;
Stakkestad, J ;
Glüer, CC ;
Krueger, K ;
Cohen, FJ ;
Eckert, S ;
Ensrud, KE ;
Avioli, LV ;
Lips, P ;
Cummings, SR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645
[8]   Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Cecchini, RS ;
Cronin, WM ;
Robidoux, A ;
Bevers, TB ;
Kavanah, MT ;
Atkins, JN ;
Margolese, RG ;
Runowicz, CD ;
James, JM ;
Ford, LG ;
Wolmark, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (22) :1652-1662
[9]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388
[10]   PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY [J].
GAIL, MH ;
BRINTON, LA ;
BYAR, DP ;
CORLE, DK ;
GREEN, SB ;
SCHAIRER, C ;
MULVIHILL, JJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1879-1886